🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “China” Clear

  1. Fuzheng 1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acquired Immune Deficiency Syndrome Virus

    small molecule active

    1 trial

  2. Fuzheng 3

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acquired Immune Deficiency Syndrome Virus

    small molecule active

    1 trial

  3. G-CSF

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Intrauterine Adhesion

    small molecule active

    1 trial

  4. GLP-1 Receptor Agonists

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Short Bowel Syndrome (SBS)

    small molecule active

    1 trial

  5. Gastrografin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    CRE-induced SBO

    small molecule active

    1 trial

  6. Gefitinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    small molecule active

    1 trial

  7. Gene detection of therapeutic drugs for chronic cardiovascular and cerebrovascular diseases

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension,Essential

    other active

    1 trial

  8. Genotype detected through GenSeizer high-throughput gene capture technology

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non - Tuberculosis Mycobacteria Lung Disease

    other active

    1 trial

  9. Group A

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Crohn Disease

    small molecule active

    1 trial

  10. Group A (clinical guideline+machine learning)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    other active

    1 trial

  11. HCQ/CQ and CAB combined treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Resistance, Disease

    small molecule active

    1 trial

  12. Hetrombopag

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hematological Disease

    small molecule active

    1 trial

  13. High Dose GGQL Decoction

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetes Mellitus, Type 2

    small molecule active

    1 trial

  14. House dust mite

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Allergic Asthma

    mab terminated

    1 trial

  15. Huangjing Yangji Formula Granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sarcopenia

    small molecule active

    1 trial

  16. Human Urinary Kallidinogenase

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    small molecule active

    1 trial

  17. Human umbilical cord mesenchymal stem cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Knee Osteoarthritis

    mab active

    1 trial

  18. Hydrogen Peroxide 3 % Topical Solution

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Warts

    small molecule active

    1 trial

  19. Hypofraction radiation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    other completed

    1 trial

  20. Hypofractionated radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer

    other active

    1 trial

  21. Immediate CEUS

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cancer

    other active

    1 trial

  22. Immunohistochemistry or genetic test

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Glioma

    other active

    1 trial

  23. Immunosuppressive therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    In-stent Restenosis Lesion

    small molecule active

    1 trial

  24. Indomethacin and Ibuprofen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ductus Arteriosus, Patent

    small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources